CBRE vs ELDN · P/E 43, rev $35.77B vs $209.6M cap
CBRE Group Inc Class A (CBRE) versus Eledon Pharmaceuticals Inc (ELDN) — a side-by-side from cached financials, not a winner call.
CBRE Group Inc Class A (CBRE) is a real estate services company listed on US.
Eledon Pharmaceuticals Inc (ELDN) is a biotechnology company listed on US.
Latest reported CBRE revenue for 2024-12-31 was $35.77B. Net income was $1.04B. Revenue was up 12.0% from 2023-12-31 to 2024-12-31. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
ELDN does not have a complete income-statement cache yet.
CBRE currently screens at market cap $41.66B and trailing P/E 42.7. ELDN currently screens at market cap $209.6M.
Not investment advice. Open the CBRE and ELDN stock pages for the full models.
Not investment advice.